Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?

We conclude that TNTs and TMs provide a new and exciting avenue for the therapeutic targeting of glioblastoma and that numerous inroads have already made into TNT and TM biology. However, to target TMs and TNTs, several advances must be made before this aim can become a reality.